EUVIMEDEUVIMED entdecken
Crossref

Acquired thiopurine resistance and mismatch repair aberrations in paediatric B‐cell acute lymphoblastic leukaemia relapse: A real‐world data integrating mutational signatures, clones and clinical thiopurine dosing patterns

Prateek Bhatia iD, Sharun Sharun, Swetha Palla iD, Samuel W Brady, Sangeetha Kirubanandhan, Sada Ansari, Minu Singh, Sreejesh Sreedharanunni, Anirban Das, Amita Trehan

British Journal of Haematology · 2026-07 · 209 (1) · 54-62

DOI: 10.1111/bjh.70560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 26.05.2026. Verfasst von Prateek Bhatia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology-Oncology Unit, Department of Pediatrics, PGIMER, Chandigarh, India. Hauptthemen laut MEDLINE: Mercaptopurine, DNA Mismatch Repair, Mutation, Drug Resistance, Neoplasm. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acquired thiopurine resistance and mismatch repair (MMR) deficiency are increasingly recognised drivers of relapse in paediatric B‐cell acute lymphoblastic leukaemia (B‐ALL); however, their real‐world genomic prevalence and link to maintenance dosing patterns remain poorly characterised. Paediatric B‐ALL relapse cases (2018–2024) were subjected to whole exome sequencing (WES; 200–250× depth; n = 70) and deep targeted sequencing (700–900×; n = 5). Per‐sample frequencies of resistance gene mutations, single‐base mutational signatures, tumour mutational burden‐high (≥10 mutations/Mb), microsatellite instability‐high (MSI‐H) and thiopurine S‐methyltransferase ( TPMT)/nucleoside diphosphate‐linked moiety X‐type motif 15 (NUDT15) status were determined. Clinical variables included the median weekly 6‐mercaptopurine (6‐MP) dose (mg/m 2 , time‐weighted) and duration of 6‐MP dose interruptions. A total of 18/75 (24%) relapse cases showed SBS87 (thiopurine‐related), SBS6/15 (MMR‐related) or Thio‐deficient mismatch repair (Thio‐dMMR) mutational signature. Thiopurine resistance clones in cytosolic 5'‐nucleotidase II ( NT5C2) (13), phosphoribosyl pyrophosphate synthetase 1 ( PRPS1) (2) or tumor protein p53 ( TP53) (7) were noted in 19/75 (25%) cases; germline or somatic clones in MMR genes were noted in 19/75 (25%). Correlation analysis revealed that both low median weekly 6‐MP dose (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MercaptopurineDNA Mismatch RepairMutationDrug Resistance, NeoplasmAntimetabolites, AntineoplasticPrecursor B-Cell Lymphoblastic Leukemia-LymphomaHumansChildChild, PreschoolFemaleMaleAdolescentRecurrence

Stichwörter der Autor:innen

6‐MPB‐ALLMMRmutational signaturespaediatricrelapse

Substanzen

MercaptopurineAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Pediatric Hematology-Oncology Unit, Department of Pediatrics, PGIMER, Chandigarh, India.
  • Pharmacy & Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Hematology, PGIMER, Chandigarh, India.
  • Division of Haematology Oncology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Prateek Bhatia, Swetha Palla

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Bhatia, P., Sharun, S., Palla, S., Brady, S. W., Kirubanandhan, S., Ansari, S., Singh, M., Sreedharanunni, S., Das, A., & Trehan, A. (2026). Acquired thiopurine resistance and mismatch repair aberrations in paediatric B‐cell acute lymphoblastic leukaemia relapse: A real‐world data integrating mutational signatures, clones and clinical thiopurine dosing patterns. British Journal of Haematology, 209(1), 54-62. https://doi.org/10.1111/bjh.70560

Vancouver

Bhatia P, Sharun S, Palla S, Brady SW, Kirubanandhan S, Ansari S, et al. Acquired thiopurine resistance and mismatch repair aberrations in paediatric B‐cell acute lymphoblastic leukaemia relapse: A real‐world data integrating mutational signatures, clones and clinical thiopurine dosing patterns. British Journal of Haematology. 2026;209(1):54-62. doi:10.1111/bjh.70560

BibTeX
@article{Bhatia2026,
  author = {Bhatia, Prateek and Sharun, Sharun and Palla, Swetha and Brady, Samuel W and Kirubanandhan, Sangeetha and Ansari, Sada and Singh, Minu and Sreedharanunni, Sreejesh and Das, Anirban and Trehan, Amita},
  title = {Acquired thiopurine resistance and mismatch repair aberrations in paediatric B‐cell acute lymphoblastic leukaemia relapse: A real‐world data integrating mutational signatures, clones and clinical thiopurine dosing patterns},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {1},
  pages = {54--62},
  doi = {10.1111/bjh.70560}
}
Kostenlos starten →